Copy to clipboard 
Demetra, provider of bone cements, spacers and biomaterials for orthopedic, spine and neuro applications and orthopedic infection control, announces the acquisition of Maxxspine Innovative GmbH, a German-based provider of spinal surgery solutions.
The acquisition has been completed by Osartis, a Demetra Group company, which has acquired 100% ownership and full control of Maxxspine Innovative.
Osartis will take global responsibility for Maxxspine’s activities and work closely with existing management and teams over the coming months to ensure a smooth integration and continuity for customers and partners.
Maxxspine is recognized for the development and distribution of devices for spinal surgery, with a strong presence in the German market and growing international footprint. Through this acquisition, Demetra expands its spine portfolio and reinforces its proximity to surgeons and healthcare professionals in key European markets and beyond.
Operating through established companies such as Tecres, Osartis and OsteoRemedies, Demetra continues to invest in innovation, people and sustainable growth. Additional acquisitions by Demetra have included GetSet Surgical, OrthoFundamentals and Next Science.
“The acquisition of Maxxspine is fully aligned with Demetra’s strategy to strengthen its presence in the key European spine surgery markets. By integrating highly specialised companies like Maxxspine, we further enhance our ability to stay close to surgeons and patients, delivering innovative solutions and reinforcing our role as a trusted international partner in spine care,” commented Michele Perrino, CEO of Demetra.
Source: Demetra
Demetra, provider of bone cements, spacers and biomaterials for orthopedic, spine and neuro applications and orthopedic infection control, announces the acquisition of Maxxspine Innovative GmbH, a German-based provider of spinal surgery solutions.
The acquisition has been completed by Osartis, a Demetra Group company, which has acquired...
Demetra, provider of bone cements, spacers and biomaterials for orthopedic, spine and neuro applications and orthopedic infection control, announces the acquisition of Maxxspine Innovative GmbH, a German-based provider of spinal surgery solutions.
The acquisition has been completed by Osartis, a Demetra Group company, which has acquired 100% ownership and full control of Maxxspine Innovative.
Osartis will take global responsibility for Maxxspine’s activities and work closely with existing management and teams over the coming months to ensure a smooth integration and continuity for customers and partners.
Maxxspine is recognized for the development and distribution of devices for spinal surgery, with a strong presence in the German market and growing international footprint. Through this acquisition, Demetra expands its spine portfolio and reinforces its proximity to surgeons and healthcare professionals in key European markets and beyond.
Operating through established companies such as Tecres, Osartis and OsteoRemedies, Demetra continues to invest in innovation, people and sustainable growth. Additional acquisitions by Demetra have included GetSet Surgical, OrthoFundamentals and Next Science.
“The acquisition of Maxxspine is fully aligned with Demetra’s strategy to strengthen its presence in the key European spine surgery markets. By integrating highly specialised companies like Maxxspine, we further enhance our ability to stay close to surgeons and patients, delivering innovative solutions and reinforcing our role as a trusted international partner in spine care,” commented Michele Perrino, CEO of Demetra.
Source: Demetra
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
